InStat

InStat, LLC is a clinical-stage biotechnology and medical device company based in Raleigh, North Carolina, specializing in the development of next-generation hemostatic agents. The company leverages a proprietary biomaterial platform to create thrombin-free, flowable hemostats designed to control surgical bleeding rapidly and effectively. Its lead product, the InStat Flowable Hemostat, aims to provide surgeons with a safer, more convenient alternative to traditional clotting agents by eliminating the need for complex preparation and reducing the risk of viral transmission. The company is currently advancing its technology through clinical evaluations to address significant unmet needs in intraoperative bleeding management across various surgical disciplines.